AfroCentric Investment Corporation has released its financial results for the year ending December. The JSE-listed healthcare giant reported a massive spike in revenue. However, the group also faced a significant basic loss. This was primarily due to heavy asset...
A critical legal dispute is unfolding in South Africa’s private healthcare sector. Medscheme has filed an urgent application with the Johannesburg High Court to suspend or terminate several Requests for Proposals (RFPs) issued by Bonitas Medical Fund. Furthermore, the...
AfroCentric Investment Corporation, a Johannesburg Stock Exchange-listed healthcare firm, has announced the sale of its pharmaceutical unit, Activo Health, to Portuguese pharmaceutical giant FHC Group. This sale marks a pivotal shift in AfroCentric’s operational...
As insurance giant Sanlam tightens its grip on health-fin services specialist AfroCentric, the line between public company and private control has all but vanished. What remains is a powerful lesson in strategic patience. It reveals how corporations (or businesses)...
